Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.19.3
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 1,167,222 812,120
Value 1,922,709 1,567,607
Common stocks    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 1,167,222 812,120
Value $ 1,922,709 $ 1,567,607